Business
Kane Biotech Expands Commercial Activities in the United States
WINNIPEG, Manitoba, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has signed non-exclusive distribution/sales agreements for its revyve® Antimicrobial Wound Gel® product line with Patient Care Medical (Austin, TX) and Life Biologics (Lakewood, NJ). US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray These U.S. non-exclusive distribution and sales agreem
About this update from Kane Biotech Inc.
[{"type":"image","alt":"Kane Biotech Inc.","displaySize":"","headline":null,"caption":"Kane Biotech Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r6.I5yq30fbtTHkzKWc_gQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f","width":300,"height":100}},"lazy":false},{"type":"text","content":"WINNIPEG, Manitoba, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has signed non-exclusive distribution/sales agreements for its revyve® Antimicrobial Wound Gel® product line with Patient Care Medical (Austin, TX) and Life Biologics (Lakewood, NJ).","length":324,"tagName":"p"},{"type":"image","alt":"US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","displaySize":"","headline":null,"caption":"US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","className":"","disableSlideshowImg":false,"size":{"original":{"width":274,"height":355,"url":"https://media.zenfs.com/en/globenewswire.com/0e07d8ca40e128a7c114191c8c32152d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lPaBWMulLfGVMzC2UrNMLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU0NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0e07d8ca40e128a7c114191c8c32152d","width":274,"height":355}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","length":126,"tagName":"p"},{"type":"text","content":"These U.S. non-exclusive distribution and sales agreements expand our presence in targeted sales channels and geographic markets. Life Biologics distributes nationally in advanced wound care, while Patient Care Medical distributes within Louisiana, Mississippi and the Gulf Coast specializing in in-hospital and mobile wound care facilities. Preparations are underway for initial shipments in the near term.","length":407,"tagName":"p"},{"type":"text","content":"“Expanding our U.S. distribution network remain...